Integra LifeSciences (IART): Uncertainties To Intrinsic Value Remain, Reiterate Hold

New York Stock Exchange, Wall st, New York, USA

Matteo Colombo

Investment Briefing

In my June publication covering Integra LifeSciences Holdings Corporation (NASDAQ:IART) I outlined the case to how it was not an investment-grade company based on a number of outcomes at its Boston manufacturing facility. I’ll

Source link

Leave a Reply

Your email address will not be published. Required fields are marked *